- Capital Cube•26 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Novozymes A/SHere are 5 ETF’s with the largest exposure to NVZMY-US. Comparing the performance and risk of Novozymes A/S with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to Novozymes A/S : June 30, 2016 appeared first on CapitalCube.
- Capital Cube•2 months ago
Click here to see latest analysisNovozymes A/S reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Novozymes A/S – Innophos Holdings, Inc., Codexis, Inc., Procter & Gamble Company and E. I. du Pont de Nemours and Company (IPHS-US, CDXS-US, PG-US and DD-US) that have also […] (Read more...) The post Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 appeared first on CapitalCube.
|52wk Range||37.98 - 53.21|
|Day's Range||48.79 - 49.10|
|Avg Vol (3m)||14,541|
As of 3:59 PM EDT. Market closed.